SCHEMBL22209352

SCHEMBL22209352

CCCCCCCCC(CCCCCCC)NC(=N)N

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SPHK1 Q9NYA1 3/20 0.45
SPHK2 Q9NRA0 1/20 0.45
PLA2G2C Q5R387 3/20 0.42
LMNA P02545 2/20 0.40
CYP2D6 P10635 2/20 0.38
GMNN O75496 1/20 0.38
POLB P06746 1/20 0.38
THPO P40225 1/20 0.38
MTOR P42345 1/20 0.38
BLM P54132 1/20 0.38
KDM4E B2RXH2 1/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
MAPT P10636 1/20 0.38
CETP P11597 1/20 0.38
HTT P42858 1/20 0.38
UBE2N P61088 1/20 0.38
LAP3 P28838 1/20 0.38
OPRM1 P35372 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25866575 1.00 SPHK1 (0.45) SPHK1SPHK2PLA2G2CLMNACYP2D6
SCHEMBL14547023 0.98 PLA2G2C (0.45) SPHK1SPHK2PLA2G2CLMNACYP2D6
SCHEMBL21908450 0.96 PLA2G2C (0.42) SPHK1SPHK2PLA2G2CLMNATP53
SCHEMBL11331509 0.91 PLA2G2C (0.41) SPHK1SPHK2PLA2G2C
SCHEMBL17046803 0.90 SPHK1 (0.39) SPHK1SPHK2PLA2G2CLMNACYP2D6
SCHEMBL28189421 0.89 SPHK1 (0.39) SPHK1SPHK2PLA2G2CLMNACYP2D6
SCHEMBL10546368 0.87 TSHR (0.39) SPHK1SPHK2PLA2G2CLMNACYP2D6
SCHEMBL21922525 0.86 PRSS1 (0.34) SPHK1SPHK2PLA2G2CTP53LAP3
SCHEMBL13587256 0.83 ADH1B (0.47) SPHK1SPHK2LMNACYP2D6GMNN
SCHEMBL13725523 0.83 ADH1B (0.47) SPHK1SPHK2LMNACYP2D6GMNN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10711036-B2 MALT1 inhibitors and uses thereof CORNELL UNIVERSITY (US) 2020-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10711036-B2 MALT1 inhibitors and uses thereof MALT1, BCL3, BCL6 SPHK1 2471/4885SPHK2 3432/4885PLA2G2C 2090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.